During the past decade, Ordinace Alergologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ordinace Alergologie" are "Allergic Rhinitis" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials) and "Birch Pollen Induced Rhinitis/Rhinoconjunctivitis" (1 trials). Many other conditions were trialed in "Ordinace Alergologie" in a lesser frequency.

Most popular intervention types in "Ordinace Alergologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "SUBLIVAC FIX Birch" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ordinace Alergologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ordinace Alergologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ordinace Alergologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ordinace Alergologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".